Trial Profile

Prevention of Maternal to Infant HIV Transmission in India

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 19 Apr 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Nevirapine (Primary)
Indications HIV infections
Focus Adverse reactions; Therapeutic Use
Acronyms SWEN

Most Recent Events

07 Mar 2018 Results (n=107) determining the association of various markers of inflammation with preterm birth in HIV-infected pregnant women presented at the 25th Conference on Retroviruses and Opportunistic Infections
08 Mar 2012 Efficacy analysis according to birth weight presented at the 19th Conference on Retroviruses and Opportunistic Infections.
16 Feb 2010 Combined analysis of the three SWEN trials presented at the 17th Conference on Retroviruses and Opportunistic Infections.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com